Print PDF
Stem Cell Companies Beware: FDA May Come Knocking
January 28, 2019
Chad Landmon
Bloomberg BNA Insights

Axinn partner Chad Landmon co-authored the Bloomberg BNA Insights article, "Stem Cell Companies Beware: FDA May Come Knocking."

Click here to access the article. Reproduced with permission from Copyright 2019 The Bureau of National Affairs, Inc. (800-372-1033)

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.